Seth H. Z. Fischer Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Seth H. Z. Fischer is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 61,150 shares of ESPR, which is worth approximately $68,488. The most recent transaction as insider was on May 29, 2025, when has been sold 33,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.2K
117.23% 3M change
117.23% 12M change
Total Value Held $68,488

Seth H. Z. Fischer Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2025
BUY
Grant, award, or other acquisition
-
33,000 Added 35.05%
61,150 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
23,000 Added 44.97%
28,150 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
5,150 Added 50.0%
5,150 Common Stock

Also insider at

MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
Director
AGRX
AGILE THERAPEUTICS INC Healthcare
Director
SPPI
SPECTRUM PHARMACEUTICALS INC Healthcare
Director
MIST
Milestone Pharmaceuticals Inc. Healthcare
SHZ

Seth H. Z. Fischer

Director
Boston, MA

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR